The FDA released a report February 4, 2021 indicating that Xeljanz and Xeljanz XR, medicines used to treat arthritis and ulcerative colitis, is linked to an increased risk of cancer and serious heart problems. Lawsuits are being filed and anyone who has used one or both of these medicines and then was diagnosed with cancer or a serious heart problem, needs to reach out to us to see if they qualify.